Identification of Circulating Tumor Cells in the Peripheral Blood of Lung Cancer Patients
Completed
- Conditions
- Lung Cancer
- Registration Number
- NCT00568282
- Lead Sponsor
- Stanford University
- Brief Summary
The primary aim of this study is to determine whether we can identify human lung cancer tumor cells in the peripheral blood of lung cancer patients.
- Detailed Description
The purpose of this study is to determine whether we can identify lung cancer cells circulating in the peripheral blood of lung cancer patients using cell surface markers found on cancer cells such as CD44 and epithelial specific antigen.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 219
Inclusion Criteria
Inclusion Criteria:Inclusion Criteria (Cases):
- Advanced stage (IIIB with malignant effusion or IV) histologically or cytologically confirmed NSCLC
- Patients must be newly diagnosed (untreated) or have evidence of disease progression at the time of sample collection
- ability to sign informed consent
- at least 18 years of age
Inclusion Criteria (Controls):
- no known prior or active malignancy
- ability to sign informed consent
- at least 18 years of age
Exclusion Criteria
-
history of any other cancer other than non-melanoma skin cancer within the last 5 years Exclusion Criteria:1. history of any other cancer other than non-melanoma skin cancer within the last 5 years
-
pregnant women
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method to determine whether we can identify human lung cancer tumor cells in the peripheral blood of lung cancer patients using cell surface markers found on cancer cells. 2 years
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Stanford University School of Medicine
🇺🇸Stanford, California, United States